About Us
- Contact Us
Our Technology
Our Science
- Pipeline
- Advantages of Gylden’s Candidates
News and Events
Menu Menu

You are here: Home1 / Conferences2 / Progressing Next-Generation Vaccines using Hollow Microneedle Delivery...

Progressing Next-Generation Vaccines using Hollow Microneedle Delivery – Results from the naNO-Dengue and naNO-COVID Phase I Clinical Trial

13th February 2025

Share this entry

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

/wp-content/uploads/2024/10/CompanyName-300x300.png 0 0 gatekeeper /wp-content/uploads/2024/10/CompanyName-300x300.png gatekeeper2025-02-13 08:10:312025-02-18 09:49:02Progressing Next-Generation Vaccines using Hollow Microneedle Delivery – Results from the naNO-Dengue and naNO-COVID Phase I Clinical Trial

© Gylden Pharma

Website maintained by Digital Trading

Contact Us

Emergex T cell Chikungunya Vaccine: A Model for Emergex’s Synthetic T...Novel immunopeptidomic/machine learning integrated platform for next generation...